Keyphrases
Artemether-lumefantrine
100%
Uncomplicated Malaria
100%
Artemisinin-based Combination Therapy
60%
Therapy Regimen
60%
Malaria Control
40%
Policy Decisions
20%
Travellers
20%
Non-immune
20%
Adverse Events
20%
Coartem
20%
Good Manufacturing Practice
20%
Fixed-dose Combination
20%
Nursing and Health Professions
Artemether Plus Benflumetol
100%
Antimalarial Agent
100%
Artemisinin
42%
Combination Therapy
42%
Malaria Control
28%
Returning Traveler
14%
Good Manufacturing Practice
14%
Adverse Event
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
100%
Artemether Plus Benflumetol
100%
Combination Therapy
42%
Artemisinin
42%
Good Manufacturing Practice
14%
Adverse Event
14%